These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10188872)
1. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8. Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872 [TBL] [Abstract][Full Text] [Related]
2. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21). Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974 [TBL] [Abstract][Full Text] [Related]
3. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences. Kasashima K; Sakota E; Kozu T Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282 [TBL] [Abstract][Full Text] [Related]
4. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia. Sacchi N; Schiaffonati L; Magnani I; Pappalardo C; Hughes AJ; Darfler M; Hoogeveen AT Oncogene; 1996 Jan; 12(2):437-44. PubMed ID: 8570222 [TBL] [Abstract][Full Text] [Related]
5. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21). Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886 [TBL] [Abstract][Full Text] [Related]
6. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037 [TBL] [Abstract][Full Text] [Related]
7. A distinct epigenetic signature at targets of a leukemia protein. Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773 [TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2. Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543 [TBL] [Abstract][Full Text] [Related]
9. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript]. Kazama H; Aoyama M; Sameshima Y; Teramura M; Masuda M; Motoji T; Okada M; Mizoguchi H Rinsho Ketsueki; 1996 Nov; 37(11):1297-302. PubMed ID: 8960665 [TBL] [Abstract][Full Text] [Related]
10. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461 [TBL] [Abstract][Full Text] [Related]
11. Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA. Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H J Cancer Res Clin Oncol; 1996; 122(4):254-6. PubMed ID: 8601580 [TBL] [Abstract][Full Text] [Related]
12. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia. Farra C; Awwad J; Valent A; Lozach F; Bernheim A Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22). Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Wang J; Saunthararajah Y; Redner RL; Liu JM Cancer Res; 1999 Jun; 59(12):2766-9. PubMed ID: 10383127 [TBL] [Abstract][Full Text] [Related]
16. [Rearrangements and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b]. Wang J; Xiao Z; Hao Y Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):399-402, 445. PubMed ID: 7553157 [TBL] [Abstract][Full Text] [Related]
17. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. Kitabayashi I; Yokoyama A; Shimizu K; Ohki M EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182 [TBL] [Abstract][Full Text] [Related]
18. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
19. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts. Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804 [TBL] [Abstract][Full Text] [Related]
20. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21). Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]